+351 211 369 829 INFO@OPHIOMICS.COM
Get in touch with us if you’d like to know more about our prognostic tool HepatoPredict!
Inês Coelho, Cláudia Gaspar
Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy
Ophiomics will be attending the ILTS-ILCA consensus conference in Valencia. This will be an excellent opportunity to get up to
For a small company focused on innovation, with a strong investment in R&D, flexibility and spontaneity are critical. On the